Learning that your child has Juvenile Myositis may feel overwhelming. Second opinions can confirm a diagnosis, help you understand different treatment options, and review your child’s current treatment plan to ensure it’s the right one for your family.
Myositis-specific antibodies (MSAs) are associated with certain symptoms in JM patients. In some cases, knowing the MSA of a patient may help clinicians look out for certain symptoms and guide treatment decisions.
Research is vital to finding better treatments and a cure for juvenile myositis. Cure JM funds research studies through our Cure JM Centers of Excellence and the Cure JM Clinical Care Network.
The following brochures, handouts and posters are available for online viewing and printing. If you need professionally printed copies for an event, please contact us.
The Cure JM Foundation produces a monthly newsletter with the latest news and updates about Juvenile Myositis. Please click to read past issues of the Family News.
Cure JM Foundation is a 501(c)(3) nonprofit, volunteer-managed organization dedicated to finding a cure for juvenile myositis (JM).
At age 4 Parker was diagnosed with juvenile dermatomyositis. Only 2 in a million children are affected. We started Cure JM to find a cure and help kids like Parker.